MiCardia

MiCardia Corporation announces completion of $9 million private financing

Published in Healthcare Finance, Tax and Law Weekly, October 18th, 2006

MiCardia Corporation announced completion of a $9 million series B preferred financing, which was led by HBM Biocapital with additional shares sold to Japan Asia Investment company, Ltd., the MedFocus Family of Funds, the BioStar Private Equity Fund, LLC and a number of private individuals.

The proceeds from this financing will be used to further develop the company's Dynamic adjustable cardiovascular implant technologies and initial human clinical trials for its initial products.

MiCardia is developing a technology for the minimally invasive and noninvasive adjustable cardiovascular implants for the treatment of various stages of congestive heart...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2006-10-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry